221024-42-6

Basic information

• Product Name: 1-(pentan-3-yl)hydrazine hydrochloride
• Synonyms: 1-(pentan-3-yl)hydrazine hydrochloride;3-Pentanylhydrazine hydrochloride;PENTAN-3-YLHYDRAZINE HCL
• CAS NO: 221024-42-6
• Molecular Formula: C5H15ClN2
• Molecular Weight: 138.639
• Mol File: 221024-42-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(pentan-3-yl)hydrazine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(pentan-3-yl)hydrazine hydrochloride(221024-42-6)
• EPA Substance Registry System: 1-(pentan-3-yl)hydrazine hydrochloride(221024-42-6)

Safety Data

• Hazardous Substances Data: 221024-42-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Applications:
1-(pentan-3-yl)hydrazine hydrochloride is used as a reagent and intermediate in the synthesis of various organic compounds, playing a crucial role in the development of new pharmaceuticals.
Used in Research Applications:
In research, 1-(pentan-3-yl)hydrazine hydrochloride serves as a valuable tool for studying the synthesis and properties of hydrazine derivatives, contributing to the advancement of chemical knowledge.
Used in Neurodegenerative Disease Research:
1-(pentan-3-yl)hydrazine hydrochloride may have potential applications in the study of neurodegenerative diseases, providing insights into the underlying mechanisms and aiding in the development of therapeutic strategies.
Used as a Potential Therapeutic Agent:
Due to its unique structure and properties, 1-(pentan-3-yl)hydrazine hydrochloride is being explored as a potential therapeutic agent, with the possibility of offering new treatment options for various conditions.

Upstream product

• 870-46-2 t-butoxycarbonylhydrazine 
• 96-22-0 pentan-3-one 

Downstream Products

• 30924-29-9 3-Hydrazino-pentan 

Relevant articles and documents

THIAZOLYL-DIHYDRO-INDAZOLES

The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a

FUSED HETEROCYCLIC COMPOUNDS

Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases.

HETEROCYCLIC COMPOUNDS

A pharmaceutical composition containing a heterocyclic compound of the formula (I) wherein each symbol is as defined in the specification, an isomer thereof, a solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient has a sup

Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders

Corticotropin releasing factor (CRF) antagonists of Formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress in mammals.